1. Home
  2. CYTK vs MTG Comparison

CYTK vs MTG Comparison

Compare CYTK & MTG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CYTK
  • MTG
  • Stock Information
  • Founded
  • CYTK 1997
  • MTG 1957
  • Country
  • CYTK United States
  • MTG United States
  • Employees
  • CYTK N/A
  • MTG N/A
  • Industry
  • CYTK Biotechnology: Pharmaceutical Preparations
  • MTG Property-Casualty Insurers
  • Sector
  • CYTK Health Care
  • MTG Finance
  • Exchange
  • CYTK Nasdaq
  • MTG Nasdaq
  • Market Cap
  • CYTK 5.6B
  • MTG 5.7B
  • IPO Year
  • CYTK 2004
  • MTG 1991
  • Fundamental
  • Price
  • CYTK $44.53
  • MTG $24.41
  • Analyst Decision
  • CYTK Strong Buy
  • MTG Hold
  • Analyst Count
  • CYTK 17
  • MTG 8
  • Target Price
  • CYTK $82.00
  • MTG $26.75
  • AVG Volume (30 Days)
  • CYTK 1.6M
  • MTG 3.4M
  • Earning Date
  • CYTK 05-07-2025
  • MTG 04-30-2025
  • Dividend Yield
  • CYTK N/A
  • MTG 2.15%
  • EPS Growth
  • CYTK N/A
  • MTG 16.23
  • EPS
  • CYTK N/A
  • MTG 2.89
  • Revenue
  • CYTK $18,474,000.00
  • MTG $1,207,731,000.00
  • Revenue This Year
  • CYTK $176.28
  • MTG $3.42
  • Revenue Next Year
  • CYTK $361.83
  • MTG $2.72
  • P/E Ratio
  • CYTK N/A
  • MTG $8.33
  • Revenue Growth
  • CYTK 145.34
  • MTG 4.56
  • 52 Week Low
  • CYTK $40.53
  • MTG $19.26
  • 52 Week High
  • CYTK $75.71
  • MTG $26.56
  • Technical
  • Relative Strength Index (RSI)
  • CYTK 50.85
  • MTG 54.39
  • Support Level
  • CYTK $42.66
  • MTG $22.30
  • Resistance Level
  • CYTK $48.43
  • MTG $23.85
  • Average True Range (ATR)
  • CYTK 2.09
  • MTG 0.55
  • MACD
  • CYTK 0.28
  • MTG 0.10
  • Stochastic Oscillator
  • CYTK 51.02
  • MTG 96.69

About CYTK Cytokinetics Incorporated

Cytokinetics Inc is a biotechnology company that develops muscle biology-driven treatments for diseases characterized by reduced muscle function, muscle weakness, and fatigue. The company develops treatments for diseases such as amyotrophic lateral sclerosis, heart failure, spinal muscular atrophy, and chronic obstructive pulmonary diseases. The treatment is based on small molecules specifically engineered to increase muscle function and contractility. The company is developing muscle-directed investigational medicines that may potentially improve the health span of people with devastating cardiovascular and neuromuscular diseases of impaired muscle function.

About MTG MGIC Investment Corporation

MGIC Investment Corp provides private mortgage insurance, other mortgage credit risk management solutions, and ancillary services. The insurance premiums that these customers pay for the protection accounts for close to majority of the company's total revenue. Investment income accounts for the remaining revenue. The company sells its insurance products in all states of the United States and in Puerto Rico. Its greatest exposure is in California, Florida, Texas, Pennsylvania, Ohio, Illinois, Virginia, North Carolina, Georgia and New York.

Share on Social Networks: